DrugDomain logoDrugDomain

(2R)-2-{[(4-O-hexopyranosyl-beta-D-glucopyranosyl)oxy]methyl}-4-{[(25R)-5beta,14beta,17beta-spirostan-3beta-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside

Q9HBA0 Transient receptor potential cation channel subfamily V member 4

← Back

Post-Translational Modifications (PTMs)

Info
No PTM data found